Salvage stereotactic MR-Guided adaptive radiotherapy (SMART) re-irradiation for locally recurrent prostate Cancer: Clinical and dosimetric outcomes
Daily adaptive SMART re-irradiation is a feasible, non-invasive salvage option for LRPC, combining high LC with low toxicity. Our experience supports integrating MR- guidance with an individualized EQD2-informed planning.
Authors
- Prantik Das (ORCID: https://orcid.org/0000-0003-2976-4410)
- Ami Sabharwal
- Elena Moreno-Olmedo (ORCID: https://orcid.org/0000-0001-7508-1544)
- Daniel Ford
- Yae‐Eun Suh
- Richard Michael Martin (ORCID: https://orcid.org/0000-0002-7992-7719)
- D. Stark Murray (ORCID: https://orcid.org/0009-0002-1059-9742)
- Philip Camilleri (ORCID: https://orcid.org/0000-0002-2677-5627)
- Yoodhvir Nagar
- Carla Perna (ORCID: https://orcid.org/0000-0002-3035-2408)
- Nicola Dallas (ORCID: https://orcid.org/0000-0001-6835-7143)
- James L. Mills (ORCID: https://orcid.org/0000-0003-4496-332X)
- Ben George (ORCID: https://orcid.org/0000-0002-6263-5891)
Institutions
- Genesis HealthCare (US)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1016/j.ctro.2025.101037
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00